West Pharmaceutical Services | WST - Операционный доход





Операционный доход Изменить Дата
Align Technology USD 193.04M 1.72M 2026-09
Baxter International USD 314M 38M 2026-09
Becton, Dickinson and Co. USD 1.11B 357M 2026-09
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 202.64M 82.75M 2026-09
Cooper Companies USD 222M 253M 2026-06
Dentsply International USD 38M 46M 2026-09
Haemonetics USD 75.12M 17.66M 2026-09
ICU Medical USD 58.59M 1.84M 2026-09
Insulet USD 189.8M 60.1M 2026-09
Integra LifeSciences USD 42.65M 1.36M 2026-09
IQVIA Holdings USD 608M 1.99B 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Neogen USD -1.8M 4.9M 2026-06
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD 12.1M 27.4M 2026-09
Repligen USD 24.31M 3.18M 2026-09
Rockwell Medical USD 515K 1.84M 2024-06
Solventum Corp USD 68M 113M 2026-09
STAAR Surgical USD 5.46M 4.64M 2026-09
Terumo JPY -18.68B 108.16B 2026-09
Utah Medical Products USD 2.56M 124K 2026-03
West Pharmaceutical Services USD -199.7M 378.8M 2026-09